Ad Schuurman

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Wills Hughes-Wilson, Ana Luiza do Rosário Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases · 2012 · 169 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Hans‐Georg Eichler, Brigitte Bloechl‐Daum, Karl Broich et al. · Clinical Pharmacology & Therapeutics · 2018 · 104 citations · Full text

Public Affairs, Health Administration, Pharmaceutical Policy +10

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno et al. · Frontiers in Pharmacology · 2016 · 55 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16

Evaluating building circularity in the early design phase

M. van der Zwaag, Tong Wang, H. Bakker et al. · Automation in Construction · 2023 · 32 citations · Full text

Architecture, Design, Business Intelligence +11